Association among abnormal glycolipids, reproductive hormones, and cognitive dysfunction in female patients with bipolar disorder
- PMID: 38773397
- PMCID: PMC11110249
- DOI: 10.1186/s12888-024-05831-y
Association among abnormal glycolipids, reproductive hormones, and cognitive dysfunction in female patients with bipolar disorder
Abstract
Background: Patients with bipolar disorder (BD) show abnormalities in glucolipid metabolism and reproductive hormone levels, which are of concern in women with BD. This study was dedicated to investigating the glucolipid and reproductive hormone levels of female patients, and to preliminarily investigating their relationships with cognition.
Methods: A total of 58 unmedicated female BD patients, 61 stable-medicated female BD patients, and 63 healthy controls (HC) were recruited in this study. Serum glycolipid indexes and reproductive hormones were measured. Cognitive function was assessed using the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) and the Stroop Color-Word Test (Stroop test).
Results: Patients with BD showed significant cognitive impairment (p < 0.05), which was not affected by medication. Triglycerides (TG), luteinizing hormone (LH), and high-density lipoprotein cholesterol (HDL-c) were altered in stable-medicated BD patients. In addition, regression analysis showed that progesterone (PRGE) and prolactin (PRL) were negatively associated with cognitive performance in stable-medicated BD patients.
Conclusions: Female BD patients may have cognitive deficits and abnormal levels of glycolipids and reproductive hormones. And abnormal levels of glycolipids and reproductive hormones may be associated with cognitive dysfunction in female BD patients.
Keywords: Bipolar disorder; Cognitive dysfunction; Female; Glycolipid level; Reproductive hormone.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Similar articles
-
Association between uric acid and cognitive dysfunction: A cross-sectional study with newly diagnosed, drug-naïve with bipolar disorder.J Affect Disord. 2023 Apr 14;327:159-166. doi: 10.1016/j.jad.2023.01.105. Epub 2023 Feb 2. J Affect Disord. 2023. PMID: 36739000
-
Association between abnormal glycolipid level and cognitive dysfunction in drug-naïve patients with bipolar disorder.J Affect Disord. 2022 Jan 15;297:477-485. doi: 10.1016/j.jad.2021.10.100. Epub 2021 Oct 27. J Affect Disord. 2022. PMID: 34715186
-
Association of altered thyroid hormones and neurometabolism to cognitive dysfunction in unmedicated bipolar II depression.Prog Neuropsychopharmacol Biol Psychiatry. 2021 Mar 8;105:110027. doi: 10.1016/j.pnpbp.2020.110027. Epub 2020 Aug 11. Prog Neuropsychopharmacol Biol Psychiatry. 2021. PMID: 32791168
-
Cognitive deficits in bipolar disorders: Implications for emotion.Clin Psychol Rev. 2018 Feb;59:126-136. doi: 10.1016/j.cpr.2017.11.006. Epub 2017 Nov 21. Clin Psychol Rev. 2018. PMID: 29195773 Free PMC article. Review.
-
A review on the impact of cognitive dysfunction on social, occupational, and general functional outcomes in bipolar disorder.Bipolar Disord. 2015 Dec;17 Suppl 2:41-55. doi: 10.1111/bdi.12341. Bipolar Disord. 2015. PMID: 26688289 Review.
References
-
- Merikangas KR, Jin R, He JP, Kessler RC, Lee S, Sampson NA, Viana MC, Andrade LH, Hu C, Karam EG, et al. Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch Gen Psychiatry. 2011;68(3):241–51. doi: 10.1001/archgenpsychiatry.2011.12. - DOI - PMC - PubMed
-
- Martinez-Aran A, Vieta E, Reinares M, Colom F, Torrent C, Sanchez-Moreno J, Benabarre A, Goikolea JM, Comes M, Salamero M. Cognitive function across manic or hypomanic, depressed, and euthymic states in bipolar disorder. Am J Psychiatry. 2004;161(2):262–70. doi: 10.1176/appi.ajp.161.2.262. - DOI - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous